Pfizer’s controversial takeover of Allergan has thrown a new multinational crackdown on tax avoidance into sharp reliefLess than two months ago, the finance ministers of the G20 gathered for a celebratory dinner in Peru to mark agreement on a “once-in-a-century” package of reforms to combat tax avoidance by multinational corporations that is costing governments up to $240bn a year.